Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-07-20 · Notice · Federal Register document 2026-14583

Medicare Program; Inflation Reduction Act of 2022 (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request

Official abstract: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA) (Pub. L. 117-169). CMS' draft guidance and other IRA-related guidance can be viewed on the CMS website at https://www.cms.gov/priorities/medicare- prescription-drug-affordability/medicare-prescription-drug- affordability.